What type of study is this?

September 5, 2025Open Access

NCCN guidelines focus on treatment options for patients with multiple myeloma

Key Points

NCCN guidelines emphasize updated treatment options for multiple myeloma patients, enhancing clinical decision-making.
Systemic therapy recommendations have been highlighted, focusing on newly diagnosed and previously treated cases with effectiveness.
Prostate cancer prognosis worsens with elevated PSA levels after surgery, suggesting monitoring is crucial for patient outcomes.
Dose-escalated radiation therapy improves treatment failure rates in localized prostate cancer, signifying advancements in care.

Abstract

This news section offers Cancer readers timely information on events, public policy analysis, topical issues, and personalities. In this issue, recommendations highlight important updates specific to systemic therapy options for those with newly diagnosed or previously treated multiple myeloma. In addition, a persistent PSA level following radical prostatectomy for prostate cancer is associated with a worse prognosis, and outcomes show a reduction in treatment failure associated with dose‐escalated, hypofractionated radiation therapy for localized prostate cancer.

Read Full Paperexternally

Bookmark

View Full Paper

Cite This Study

Mary Beth Nierengarten (Sun,) studied this question.

synapsesocial.com/papers/68bb49bc6d6d5674bccff43d https://doi.org/https://doi.org/10.1002/cncr.70014

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Bookmark

View Full Paper